ENTITY
Aarti Drugs

Aarti Drugs (ARTD IN)

28
Analysis
Health Care • India
Aarti Drugs is a prominent Indian pharmaceutical company specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. It produces over 50 API molecules and 80+ finished products for various therapeutic segments, including anti-protozoals, anti-inflammatory, antibiotics, and antidiabetics, serving both domestic and international markets. The company was founded in 1984 and is headquartered in Mumbai, Maharashtra, India.
more
•07 Apr 2025 14:52

Capex Monetization: Revenue Impact, Margin Expansion Across Companies

​Companies are expanding capacity to meet strong demand, improve financial performance, and create long-term value, positioning them for...

Logo
515 Views
Share
•22 Nov 2015 13:18

Profit from India's Rapidly Growing Biotechnology Industry

Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...

Logo
5.1k Views
Share
•01 Mar 2015 23:26

India's Budgets: 2006-2015. Key Charts, and Key questions

In continuation of my work of detailed work on India Budget for last ten years, this piece through simple charts puts in perspective:  2014 Actual...

Share
bearish•Sagility
•26 May 2025 22:46

Sagility India IPO Lockup - US$1.5bn Lockup Release; PE Promoter Will Have to Trim for Free-Float

Sagility B.V. plans to offload up to 15.02% stake in Sagility India via block deals worth INR26.7bn (US$314.7m). The secondary share sale is priced...

Logo
1.1k Views
Share
bullish•Aarti Drugs
•06 Feb 2025 11:30

The Beat Ideas: Aarti Drugs Revival

​US FDA approvals for Tarapur & Baddi facilities will boost revenues and margins, allowing entry into regulated US market and expanding market...

Logo
546 Views
Share
x